Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: A double-blind, placebo-controlled, comparative study-Reference-Cited by-同舟云学术

Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: A double-blind, placebo-controlled, comparative study

Published:1998-06 Issue:6 Volume:9 Page:661-666
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Goedhals L.,Heron J.-F.,Kleisbauer J.-P.,Pagani O.,Sessa C.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/9/6/661/19481872/9-6-661.pdf

Reference28 articles.

1. Potential for combination therapy with the new antiserotonergic agents;Grunberg;Eur J Cancer,1993

2. the Granisetron Study Group. A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic-induced emesis;Marty;Eur J Cancer,1992

3. The control of acute cisplatin-induced emesis – a comparative study of granisetron and a combination of high-dose metoclopramide and dexamethasone;Chevallier;Br J Cancer,1993

4. Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting;De Mulder;Ann Intern Med,1990

5. Tropisetron, a review of the clinical experience;De Bruijn;Drugs,1992

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of ondansetron against emesis induced by a multiple-day cisplatin-based chemotherapy regimen for malignant lymphoma;Hematology;2021-01-01

2. Persistent Severe Hiccups After Dexamethasone Intravenous Administration;American Journal of Case Reports;2019-04-30

3. Incidence of nausea and vomiting in breast cancer patients treated with anthracycline plus cyclophosphamide-based chemotherapy regimens in Italy: NAVY observational study;Supportive Care in Cancer;2018-06-25

4. A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapy;Medicine;2018-06

5. Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy;Journal of the Egyptian National Cancer Institute;2017-09